Pennsylvania

Home
About The PaACC
Members
Communications/Publications
Meetings & Events
Advocacy
Online Education
Links of Interest
Practice Management
Job Opportunities
Latest Cardiology News
Contact Us

Online Education

2009 Chapter Meeting Presentations

2008 Chapter Meeting Presentations

2007 Chapter Meeting Presentations

Type-2 Diabetes Mellitus - Learn more about Type-2 Diabetes Mellitus since long-term complications of diabetes include CVD. In fact, two out of three people with diabetes die from CVD.


2009 Chapter Meeting Presentations:

The 2009 PaACC Chapter Meeting was held October 2 - 4, 2009 at Skytop Lodge in Skytop, PA.
Presentations from the meeting are listed here in an easy-to-use Adobe PDF format. After clicking on a file, click "open" to view the presentation, or save to your computer.

ACC Cut the Cuts Campaign
by Alfred A. Bove, MD, PhD, FACC
Quality Aspect of Health Reform
by Joseph G. Cacchione, MD
Real-Time MRI Guided Intervention
by Henry R. Halperin, MD, MA, FAHA
Minimally Invasive Cardiac Surgery and Complex Valve Recinstruction
by Y. Joseph Woo, MD
Therapeutic Application of Stem Cells in Cardiovascular Disease
by Oscar C. Marroquin, MD, FACC, FSCAI
The Use of Cardiac CT and MRI in Clinical Practice
by Matthew W. Martinez, MD
New Developments In the Management of Aortic and Mitral Valve Disorders
by Patricia A. Pellikka, MD
Maintenance of Certification (MOC) for Cardiologists
by Laura Wexler, MD, FAHA, FACC
When to Cool? Clinical Applications of Therapeutic Hypothermia
by Clifton W. Callaway, MD, PhD


2008 Chapter Meeting Presentations:

The 2008 PaACC Chapter Meeting was held October 31st - November 2nd at the Hotel Hershey in Hershey, PA.
Presentations from the meeting are listed here in an easy-to-use PPS (PowerPoint Show) format. After clicking on a file, click "open" to view the presentation. You do not need to have MS PowerPoint installed on your computer to view the files.

Quality First
by Alfred A. Bove, MD, PhD, FACC
2008 Update: Tools for the Management of Stable Angina A Brain; Heart; and COURAGE
by Daniel Edmundowicz, MS, MD, FACC
Percutaneous Valve Repair and Replacement
by Howard C. Herrmann, MD, FACC
Increased Awareness of Legislative and Regulatory Issues
by C. Richard Schott, MD, FACC
PCI vs Medical Therapy for Stable Angina
by A.J. Conrad Smith, MD, FACC
Treating Decompensated and Stage D Heart Failure
by Ronald S. Freudenberger, MD, FACC
CP / Emergence of Cardiac CT
by William A. Van Decker, M.D.
HDL: Still a target for therapy?
by Daniel J. Rader, MD
ICD Patients/Recalled ICDS: What to do?
by Gerald V. Naccarelli M.D.



2007 Chapter Meeting Presentations:

Presentations from the Annual Chapter Meeting held October 12-14, 2007.
All files are in a MS PowerPoint Show (.PPS) format. You do not need to have MS PowerPoint Installed on your computer to view the files. Each link opens a new window.

Transforming Science into Quality Care
by Alfred A. Bove, MD, PhD
Treat Everyone to an LDL-C or 70mg/dl?
by Daniel Edmundowicz MS, MD, FACC
Reimbursement Challenges and Solutions for Cardiovascular Specialists
by Kathleen Flood, Director, Payer Advocacy
Gloom, Doom, and the Baby Boom: HealthCare in the Future
by Raymond J. Gibbons, MD [ File 1 ] [ File 2 ]
Negotiating Your Employment Contract
by Vasilios J.Kalogredis, Esq.
Treatment of Atrial Fibrillation: 2007 Update
by David L. Scher, FACP, FACC, FHRS
Achieving Accreditation in Echo, Nuclear and Vascular
by Robert Skotnicki DO, FACC
LDL: Lower IS Better
by Andrew R. Waxler, MD, FACC
Task Force on Performance Assessment, Recognition, Reinforcement and Reward (PAR3)
by Janet Wright MD, FACC


Type-2 Diabetes Mellitus:

T2DM Drivers

Driver One
Reducing blood glucose and HbA1c levels reduces the risk of diabetic complications. Intensive therapy has been shown to be superior to conventional therapy in terms of reducing glycemia and diabetic complications.

Driver Two
When monotherapy with an oral agent is no longer adequate, combination therapy with two or more oral agents has been shown to significantly improve glycemic control.

Driver Three
When oral monotherapy or combination oral therapy is no longer adequate, insulin can be added to the regimen to significantly improve glycemic control.

Driver Four
Benefits of insulin therapy, such as improved outcomes and glycemic control, outweigh risks such as the potential for inducing hypoglycemia.

Driver Five
Type 2 diabetes mellitus is a disease consisting of two components: insulin resistance and insulin deficiency.

Read the full diabetes module for cardiology.

This Scientific Evidence Based Medicine Module was funded by an educational grant from Sanofi-Aventis Pharmaceuticals Education Center.